↓ Skip to main content

Cochrane Database of Systematic Reviews

Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

blogs
1 blog
twitter
7 tweeters

Citations

dimensions_citation
99 Dimensions

Readers on

mendeley
144 Mendeley
Title
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd001245.pub2
Pubmed ID
Authors

Merih I Baharoglu, Menno R Germans, Gabriel JE Rinkel, Ale Algra, Marinus Vermeulen, Jan van Gijn, Yvo BWEM Roos

Abstract

Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. Rebleeding is probably related to dissolution of the blood clot at the site of aneurysm rupture by natural fibrinolytic activity. This review is an update of a previously published Cochrane review.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
China 1 <1%
Germany 1 <1%
Unknown 142 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 17%
Researcher 22 15%
Student > Doctoral Student 16 11%
Other 14 10%
Student > Bachelor 11 8%
Other 33 23%
Unknown 23 16%
Readers by discipline Count As %
Medicine and Dentistry 83 58%
Nursing and Health Professions 13 9%
Neuroscience 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Computer Science 1 <1%
Other 6 4%
Unknown 30 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2021.
All research outputs
#2,103,010
of 17,342,898 outputs
Outputs from Cochrane database of systematic reviews
#4,790
of 11,657 outputs
Outputs of similar age
#21,699
of 169,526 outputs
Outputs of similar age from Cochrane database of systematic reviews
#49
of 131 outputs
Altmetric has tracked 17,342,898 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,657 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.9. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 131 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.